Gadolinium Information

The US Food and Drug Administration has recently become aware of a number of cases of Nephrogenic Systemic Fibrosis occurring in some individuals with advanced kidney disease and kidney failure. These individuals had recently undergone an MRI or MRA procedure using a Gadolinium based MRI contrast agent to enhance the images obtained the procedure. There [...]

Nephrogenic Systemic Fibrosis is a condition that causes the skin on the extremities to become thick and harden, causing debilitation, severe pain, and disfiguring the person that it affects. The condition only occurs in patients with advanced kidney disease or kidney failure and then, only after they have been exposed to a Gadolinium based contrast [...]

In 2006, a report was released detailing a rare condition affecting a small number of individuals suffering from kidney damage and kidney failure. The condition was called Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD) and was considered potentially life threatening. All of the patients detailed in the report had received a Gadolinium based [...]

Nephrogenic systemic fibrosis, also known as nephrogenic fibrosing dermopathy, is a debilitating disorder affecting the skin. The condition affects both men and women of every age, from infants to the elderly, but typically occurs in individuals that are middle aged. The condition can affect individuals of every ethnicity and has been found mainly in Europe, [...]

A public health advisory was recently issued by the US Food and Drug Administration warning about a severe disorder associated with advanced kidney disease and the use of gadolinium based contrast agents used during magnetic resonance imaging (MRI). As of December 2006, the agency had received over 90 reports of patients suffering from advance kidney [...]

Gadolinium is considered a paramagnetic metal ion, a substance that is known to move into magnetic fields. It is this property that makes Gadolinium so useful in Magnetic Resonance Imaging (MRI) and was approved for this use by the US Food and Drug Administration (FDA) in 1988. The substance is used as a contrast agent, [...]

Recent research has discovered a disturbing issue that has arisen with the use of MRI contrast agents containing Gadolinium. A side effect of using the contrast agents could cause a excruciating disfiguring condition in patients with advanced kidney disease or kidney failure. The condition is called Nephrogenic Systemic Fibrosis and is observed in these patients [...]

Gadolinium has been used for years in the enhancement of MRI images on thousands of patients without a large number of serious adverse events occurring. The US Food and Drug Administration approved Gadolinium for use in MRI procedures in 1988 and since then they have approved five specific Gadolinium based contrast agents for usage in [...]

The recent information disclosed about the use of Gadolinium based contrast agents and the development of Nephrogenic Systemic Fibrosis in patients with advanced cases of kidney disease or kidney failure has prompted the American College of Radiology (ACR) to revise its safety guidelines detailing how to safely perform an MRI procedure. The first public health [...]

Gadolinium is considered a paramagnetic metal ion, a substance that is known to move into magnetic fields. It is this property that makes Gadolinium so useful in Magnetic Resonance Imaging (MRI) and was approved for this use by the US Food and Drug Administration (FDA) in 1988. The substance is used as a contrast agent, [...]

Gadolinium is a contrast agent solution used during an MRI or magnetic resonance imaging. Commonly used to detect tumors in the body and brain, Gadolinium is injected into the bloodstream where it highlights the features of the body and displays any abnormal growths when exposed to MRI scanning. The solution is colorless, resembling clear water [...]

Nephrogenic Fibrosing Dermopathy (NFD) is a serious, life-threatening skin disorder, which has recently been linked to the use of gadolinium-based contrast agents during MRI or MRA procedures.
What is Nephrogenic Fibrosing Dermopathy?
Nephrogenic Fibrosing Dermopathy (NFD), also known as Nephrogenic Systemic Fibrosis (NSF), is a skin condition that is often described as a swelling and tightening of the skin, [...]

Nephrogenic Systemic Fibrosis (NSF) is a serious, life-threatening skin disorder, which has recently been linked to the use of gadolinium-based contrast agents during MRI or MRA procedures.
What is Nephrogenic Systemic Fibrosis?
Nephrogenic Systemic Fibrosis (NSF), also known as Nephrogenic Fibrosing Dermopathy (NFD), is a skin condition that is often described as a swelling and tightening of [...]

Gadolinium Based Contrast Agents have been linked to a serious, life-threatening skin disorder called Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD).
If you or somebody you know has developed a skin irritation or a problem with limb mobility after having received an MRI or MRA, you need to speak with your doctor immediately. These [...]